Consumable Gases and Related Products for Laboratory Use

The Food and Drug Administration (FDA) is conducting a market survey to assess the availability and potential technical capability of small businesses as defined by NAICS code 325120 to provide Laboratory Gas Tank Rental and Gases.

The Food and Drug Administration’s (FDA) Pacific Northwest Laboratory (PNL) conducts research in and analyses of human and animal food to support FDA’s mission of protecting the American public health.  To accomplish PNL’s workplan goals and congressional mandates, PNL requires commercially available consumable high purity and high-quality laboratory grade compressed gases, related gas products such as dry ice, and liquid nitrogen to prepare regulatory samples and to operate laboratory scientific instruments.  The results generated from the regulatory samples will be evaluated and used by the agency to implement regulatory actions and accomplish its mission.

Minimum Technical Requirements:  

The Contractor shall provide delivery of the reagents as listed in the Deliverables section below.  The Contractor shall work with the Delivery Order Technical Point of Contact (TPC) to coordinate shipping.

Deliverables

See attached document for deliverables. 

Shipping Destination

U.S. Food and Drug Administration

Pacific Northwest Laboratory (PNL)

Attn: To Be Determined at the time of the award

22201 23rd Drive Southeast

Bothell, Washington 98021

Period of Performance

The Period of Performance is as follows:

Base Period    –  June 13, 2020 – June 14, 2021

Option Year 1 – June 13, 2021 – June 14, 2022

Option Year 2 – June 13, 2022 – June 14, 2023

Option Year 3 – June 13, 2023 – June 14, 2024

Option Year 4 – June 13, 2024 – June 14, 2025

The information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Respondents shall specify and document that their NAICS code is 325120 and provide proof of their business size.

This is a request for information and shall not be construed as a solicitation or obligation on the part of the FDA for any future solicitation. Telephone inquiries will not be accepted.

All interested parties shall submit their capability statements via email to be received by May 22, 2020, at 1:00 p.m Eastern Time, to the Contracting Office Address: Food and Drug Administration, Michael Gemmill, Contract Specialist, Michael.Gemmill@fda.hhs.gov